Welcome and Introduction
Faculty Panel

Thromboprophylaxis Across the Arteriovenous Spectrum-Focus on VTE Prevention, New Mechanisms, and Emerging Agents for “Red (Arterial) States” and “Blue (Venous) States”
Stavros V. Konstantinides, MD

Mechanisms of Atherothrombotic Events as a Basis for Preventive Therapies-Focus on Antithrombotic Strategies and Factor Xa Inhibition
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI

Acute Coronary Syndrome (ACS)-Achieving Effective Secondary Prevention of Thrombosis-Related Events: Factor Xa Inhibition and The Optimal Balance Between Anti-Ischemic Efficacy and Bleeding Risk Reduction
John H. Alexander, MD, MHS, FACC

Challenges in Managing Bleeding Risk Across the Spectrum of Arterial and Venous Thromboprophylaxis: Strategies for Mitigating Adverse Events in Atrial Fibrillation, ACS, and VTE Prophylaxis-Current Options and Emerging Opportunities
Sunil V. Rao, MD

Question and Answer Session
Faculty Panel